Immunoenhanced enteral nutrition, effect on inflammatory markers in head and neck cancer patients

Abstract

The aim of our study was to evaluate the effect of enteral nutrition supplemented with arginine in inflammatory markers in surgical head and neck cancer patients. A population of 29 patients with oral and laryngeal cancer were enrolled in a randomized trial. At surgery patients were randomly allocated to two groups: (a) patients receiving an enteral diet supplements with arginine (group I, n=14); (b) patients receiving an isocaloric, isonitrogenous enteral formula (group II, n=15). The mean age was 61.1±10.8y (five females/24 males). Characteristics of the patients on enrollment were similar for the two groups. Prealbumin and transferrin improved in both groups. c-reactive protein (CRP) levels decreased in both groups, (group I: 134.5±62.5 vs 75.3±51 mg/dl:P<0.05) and (group II: 103.6±62 vs 43.8±34.4 mg/dl:P<0.05). Interleukin-6 (IL-6) improved in both groups (group I: 20.35±11.2 vs 6.7±3.1 pg/ml:P<0.05) and (group II:22.8±40 vs 9.9±17.7 pg/ml:ns). Tumoral necrosis factor alpha and lymphocytes did not change. In conclusion, both formulas improved IL-6 and CRP levels. Further studies are needed to determine whether type of formula is the key in these patients or genetic background play a main role in inflammatory response. © 2005 Nature Publishing Group All rights reserved.